CNRMF (China Regenerative Medicine International) GF Value Rank: 2 (As of Aug. 08, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CNRMF China Regenerative Medicine International Ltd CNRMF
30 GF Score
Price $0.04
GF Value $0.09
! 5 Warning Signs
View Full Analysis

What is China Regenerative Medicine International GF Value Rank?

China Regenerative Medicine International CNRMF 30 GF Value Rank is 2 as of Aug. 08, 2026, which is at its 10-year median of 2.00. GuruFocus rates CNRMF with a GF Scoreâ„¢ of 30/100 and a GF Valueâ„¢ of $0.09. The stock has 5 warning signs investors should review.

China Regenerative Medicine International has the GF Value Rank of 2.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


China Regenerative Medicine International GF Value Rank Related Terms


CNRMF vs VRTX, REGN, RVMD: GF Value Rank Comparison

For the Biotechnology subindustry, China Regenerative Medicine International's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Regenerative Medicine International GF Value Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, China Regenerative Medicine International's GF Value Rank distribution charts can be found below:

* The bar in red indicates where China Regenerative Medicine International's GF Value Rank falls into.


CNRMF
30GF Score
China Regenerative Medicine International Ltd CNRMF
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 2 mean?
China Regenerative Medicine International (CNRMF) has a GF Value Rank of 2 as of Aug. 08, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on China Regenerative Medicine International and its competitors. This is near median its historical median of 2.00. Over the past decade, China Regenerative Medicine International's GF Value Rank has ranged from 2.00 to 8.00.
Is China Regenerative Medicine International's GF Value Rank too high?
China Regenerative Medicine International's current GF Value Rank of 2 is near median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. Overall, China Regenerative Medicine International has a GF Scoreâ„¢ of 30/100, reflecting its overall financial health beyond just this single metric.
How does China Regenerative Medicine International's GF Value Rank compare to VRTX and REGN?
China Regenerative Medicine International's GF Value Rank of 2 can be compared against companies in the Biotechnology industry. Historically, China Regenerative Medicine International's own GF Value Rank has ranged from 2.00 to 8.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for a Biotechnology company?
A good GF Value Rank depends on the Biotechnology industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on China Regenerative Medicine International and its competitors. China Regenerative Medicine International's current GF Value Rank is 2, which is near median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Regenerative Medicine International stock overvalued right now?
China Regenerative Medicine International (CNRMF) has a current GF Value Rank of 2. The stock's GF Value™ is $0.09, compared to a current price of $0.04 — trading 61.1% below its estimated fair value. The current GF Value Rank is 2, which is near median its 10-year median of 2.00. China Regenerative Medicine International's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For China Regenerative Medicine International (CNRMF), the current GF Value Rank is 2 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Regenerative Medicine International (CNRMF) Overvalued in 2026?

Based on GuruFocus' analysis, China Regenerative Medicine International stock appears to be undervalued. The current stock price of $0.04 is trading 61.1% below its estimated GF Value™ of $0.09.

Key valuation signals for CNRMF:

  • GF Value Rank: 2 (near median its 10-year median of 2.00)
  • GF Value™: $0.09 vs. price of $0.04 (61.1% below fair value)
  • GF Score™: 30/100 with 5 warning signs

No single metric tells the full story. See the CNRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Regenerative Medicine International Business Description

Other Exchanges 08158:Hong Kong
Address 132 Nathan Road, Suite 2310-2318, Miramar Tower, Tsim Sha Tsui, Kowloon, HKG
China Regenerative Medicine International Ltd is an investment holding company. The company is engaged in the provision of healthcare products and services. It is engaged in research and development, production and sales of tissue engineering and regenerative medicine products. The business scope of company includes tissue engineering, cosmetics, cell storage, preparation and therapy, hospitals administration and other business division. The segments of the company are Aesthetic medical and beauty services and Medical services. The majority of the company's revenue is derived from its Aesthetic medical and beauty services segment that provides medical beauty products and services. Geographically, the Hong Kong accounts for the majority of the revenue and also has a presence in PRC.
30GF Score

Get the complete analysis for CNRMF

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.04
Price
$0.09
GF Value